<code id='FD7885F2A8'></code><style id='FD7885F2A8'></style>
    • <acronym id='FD7885F2A8'></acronym>
      <center id='FD7885F2A8'><center id='FD7885F2A8'><tfoot id='FD7885F2A8'></tfoot></center><abbr id='FD7885F2A8'><dir id='FD7885F2A8'><tfoot id='FD7885F2A8'></tfoot><noframes id='FD7885F2A8'>

    • <optgroup id='FD7885F2A8'><strike id='FD7885F2A8'><sup id='FD7885F2A8'></sup></strike><code id='FD7885F2A8'></code></optgroup>
        1. <b id='FD7885F2A8'><label id='FD7885F2A8'><select id='FD7885F2A8'><dt id='FD7885F2A8'><span id='FD7885F2A8'></span></dt></select></label></b><u id='FD7885F2A8'></u>
          <i id='FD7885F2A8'><strike id='FD7885F2A8'><tt id='FD7885F2A8'><pre id='FD7885F2A8'></pre></tt></strike></i>

          Home / fashion / explore

          explore


          explore

          author:leisure time    Page View:921
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In